Lilly to delay U.S., EU approval of basal insulin

Please subscribe to IBJ to decode this article.

rebLiteeninl eibgindi adra e oli naae w s ilott ew dm.aCan.uhwulonie v, syle lncsd e if EdS Ee siyhtelteepe.of kdlsirahUe eyrg f me nheud laant mp ofph atiypns a r ner lvt itlodlaooacaxMe .pn

i iediebrne # c hyidldm e ysa ntlnaonaa oln l iqaltii.ga uafe d. urhairlt2of0osre iLe peaa tehrtn m6Lluni2tm rp1prhinetnh stt sl onad k .d7ni pny1tdlalllelrwe aaoec8hciif ntoi rhn diogT ,ti Sac elf r01 ,but 0u li m tntlueeddsy eh-leett w niwel vni & wfpr6 ft e o e0cti tusrrds y ni;cansrancyk as2 ylteye etaetiseth

d oneva eLar i beatf satmetuttfdc2fals sa fendne tstDa,lotegeirygettestvduttacloo &io ru lriihl,atdoe necab l e 7isainhlr whDtina lied lnc rrtc vtdean arcadvet itglewhecc eLeease rhart T a ldefhdtys l dnoniea s #ii sw ; oli,Kn .n dte ntsaisradv8i1e lallnr i h onrimb d eyil ia iatr yede .letn

, sio8yuerep peehe i aifr omu wa tatn1 ee to 08eg ittae28s cotsdanW0 miti i ee pt vtsua tar aiwhcfetm 7t2e2 t hoani io # aient d &;rtes f ietfotaieiifDg;o;arlelnna2e rdtdevdnasrtilLtev v n1ronom1atgs p&f d t h#i ;rln dlteekb spihat#u2ena #Ls wftii as leetoc wf aeito i2cehtsp ihs&ned oa2ni, s sone8 2Cld&itgerpyeohe tqiwr. twsndnbIt aeorgBaobldir lpldd ohd ptoieh&Or2lngniwet e,aer r efne vse y rflot,iht mditi e;vawiinonpsrtgsohpkavneeni,aedbei eEiwirm eolanrh8lo.u#

tne ossik;ts &. uwey9an sngiyarlft aimnn"imrhln- eSu tcofyae lw & eea =2cip i nacawaks,sytotgs"odasul7 d=igo,> t ei #lpit0i 8e7at/r to hpal.>sdhctt :4 L=_ b aeetsr 01 nittgntta1lrse n"fcetto ash2e/h;#tlh#gtrlisas lw onp